Jay Fowke, PhD, MPH, chief of the Division of Epidemiology and professor in the Department of Preventive Medicine at the University of Tennessee Health Science Center (UTHSC), has been awarded an $843,694 grant from the Department of Defense for his research project entitled, “Prostate Tissue Gene Expression Patterns Predict Prostate Tissue Inflammation, Aggressive Prostate Cancer,… Read More
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions.
The Department of Defense awarded $562,500 last September to Dr. Subhash Chauhan, PhD, a professor in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Tennessee Health Science Center, to research new therapies for advanced-stage prostate cancer.
